A carregar...
New drugs in multiple myeloma – role of carfilzomib and pomalidomide
Carfilzomib (CFZ), an epoxyketone with specific chymotrypsin-like activity, is a second-generation proteasome inhibitor with significant activity in patients with relapsed and refractory multiple myeloma. On July 20, 2012, the US Food and Drug Administration approved CFZ to treat patients with multi...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4037992/ https://ncbi.nlm.nih.gov/pubmed/24876816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.40175 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|